Management's Discussion and Analysis of Financial Condition and Results of
Operations ("MD&A") is intended to inform the reader about matters affecting the
financial condition and results of operations of Primerica, Inc. (the "Parent
Company") and its subsidiaries (collectively, "we", "us" or the "Company") for
the period from December 31, 2019 to March 31, 2020. As a result, the following
discussion should be read in conjunction with MD&A and the consolidated
financial statements and notes thereto that are included in our Annual Report on
Form 10-K for the year ended December 31, 2019 ("2019 Annual Report"). This
discussion contains forward-looking statements that constitute our plans,
estimates and beliefs. These forward-looking statements involve numerous risks
and uncertainties, including, but not limited to, those discussed under the
heading "Risk Factors" in the 2019 Annual Report and in Item 1A of this Report.
Actual results may differ materially from those contained in any forward-looking
statements.

This MD&A is divided into the following sections:



  • Business Overview


  • Business Trends and Conditions


  • Factors Affecting Our Results


  • Critical Accounting Estimates


  • Results of Operations


  • Financial Condition


  • Liquidity and Capital Resources

Business Overview



We are a leading provider of financial products to middle-income households in
the United States and Canada through a network of independent contractor sales
representatives ("sales representatives" or "sales force"). We assist our
clients in meeting their needs for term life insurance, which we underwrite, and
mutual funds, annuities, managed investments and other financial products, which
we distribute primarily on behalf of third parties. We have two primary
operating segments, Term Life Insurance and Investment and Savings Products; and
a third segment, Corporate and Other Distributed Products.

Term Life Insurance. We distribute the term life insurance products that we
underwrite through our three issuing life insurance company subsidiaries:
Primerica Life Insurance Company ("Primerica Life"), National Benefit Life
Insurance Company ("NBLIC"), and Primerica Life Insurance Company of Canada
("Primerica Life Canada"). Policies remain in force until the expiration of the
coverage period or until the policyholder ceases to make premium payments. Our
in-force term life insurance policies have level premiums for the stated term
period. As such, the policyholder pays the same amount each year. Initial policy
term periods are between 10 and 35 years. While premiums typically remain level
during the initial term period, our claim obligations generally increase as our
policyholders age. In addition, we incur significant upfront costs in acquiring
new insurance business. Our deferral and amortization of policy acquisition
costs and reserving methodology are designed to match the recognition of premium
revenues with the timing of policy lapses and the payment of expected claims
obligations.

Investment and Savings Products. In the United States, we distribute mutual
funds, managed investments, variable annuity, and fixed annuity products of
several third-party companies. We provide investment advisory and administrative
services for client assets invested in our managed investments program. We also
perform distinct transfer agent recordkeeping services and non-bank custodial
services for investors purchasing certain mutual funds we distribute. In Canada,
we offer our own Primerica-branded mutual funds, as well as mutual funds of
other companies, and segregated funds, which are underwritten by Primerica Life
Canada.

Corporate and Other Distributed Products. Our Corporate and Other Distributed
Products segment consists primarily of revenues and expenses related to other
distributed products, including closed blocks of various insurance products
underwritten by NBLIC, prepaid legal services, and other financial products.
These products, except for closed blocks of various insurance products
underwritten by NBLIC, are distributed pursuant to distribution arrangements
with third-party companies through the independent sales force. Net investment
income earned on our invested asset portfolio is recorded in our Corporate and
Other Distributed Products segment, with the exception of the assumed net
interest accreted to our Term Life Insurance segment's future policy benefit
reserve liability less deferred acquisition costs.  Interest expense incurred by
the Company is attributed solely to the Corporate and Other Distributed Products
segment.

Business Trends and Conditions



The relative strength and stability of financial markets and economies in the
United States and Canada affect our growth and profitability. Our business is,
and we expect will continue to be, influenced by a number of industry-wide and
product-specific trends and conditions. Economic conditions, including
unemployment levels and consumer confidence, influence investment and spending
decisions by middle-income consumers, who are generally our primary clients.
These conditions and factors also impact prospective recruits' perceptions of
the business opportunity that becoming a sales representative offers, which can
drive or dampen recruiting. Consumer spending and borrowing levels affect how
consumers evaluate their savings and debt management plans. In addition,
interest rates and equity market returns impact consumer demand for the savings
and investment products we distribute. Our



                                       25

--------------------------------------------------------------------------------

customers' perception of the strength of the capital markets may influence their decisions to invest in the investment and savings products we distribute.



The financial and distribution results of our operations in Canada, as reported
in U.S. dollars, are affected by changes in the currency exchange rate. As a
result, changes in the Canadian dollar exchange rate may significantly affect
the result of our business for all amounts translated and reported in U.S.
dollars.

During the first quarter of 2020, market conditions have changed rapidly due to
the impact of the novel Coronavirus ("COVID-19") pandemic. Measures taken to
combat the spread of COVID-19 have led to an economic downturn in the United
States and Canada that is likely to continue for the foreseeable future and will
have repercussions on our business. To date this economic downturn has resulted
in extraordinary unemployment rates, lower household income, and lower consumer
spending. The resulting significant decline in North American equity markets
during the first quarter has decreased the value of clients' investment accounts
and will likely cause asset-based revenues in our investment and savings
products to decrease. In addition, major declines in bond prices have adversely
affected the fair value of our invested asset portfolio and resulted in an
increase in unrealized losses as of March 31, 2020. Such unrealized losses could
lead to further recognition of credit losses in subsequent periods if credit
conditions of the underlying security issuers worsen. The impact of economic
conditions caused by the spread of COVID-19 on our operating results in the
first quarter of 2020 is discussed in more detail later in this section, the
Results of Operations section, and the Financial Condition section.

Due to the evolving and highly uncertain nature of this event, it currently is
not possible to estimate the impact the COVID-19 pandemic will have on our
business in future periods. However, we believe the effect of COVID-19 could
create uncertainty in the following business trends and conditions:

      •  Social distancing measures could challenge the effectiveness of our
         ability to attract new recruits and retain and motivate sales
         representatives as remote communication tools may not effectively
         replace face-to-face interactions.


      •  The ability for new recruits to obtain the requisite licenses to sell

our products will likely be limited by the availability of licensing

jurisdictions to administer exams and maintain licensing operations.

• Our medical underwriting vendors have limited capacity in this

environment to handle the paramedic testing requirements needed to issue

certain types of term life insurance policies, thereby possibly limiting

new policy sales.

• We may experience an increase in mortality expense due to premature

deaths of our insureds caused by the COVID-19 disease. Any increase in

mortality expense would be mitigated by reinsurance as we have ceded a

significant majority of our mortality risk to reinsurers we believe to

be creditworthy.

• The prolonged impact of high unemployment and lower household income may

adversely impact the persistency of existing term life insurance

policies. Refer to the Factors Affecting Our Results section for more


         information about how lower persistency impacts our financial results.


      •  Instability of equity markets hampers demand for the investments and
         savings products we distribute. This dynamic leads to decreased cash
         flows earned in the form of upfront sales-based revenue and lower
         earnings of asset-based trail commissions earned from client assets
         under management.

The effects of business trends and conditions on our quarterly results are discussed below, in the Results of Operations section, and in the Financial Condition section.

Size of the Independent Sales Force.



Our ability to increase the size of the independent sales force is largely based
on the success of the sales force's recruiting efforts as well as training and
motivating recruits to get licensed to sell life insurance. We believe that
recruitment and licensing levels are important to sales force trends, and growth
in recruiting and licensing is usually indicative of future growth in the
overall size of the sales force. Changes in the number of new recruits do not
always result in commensurate changes in the size of the licensed sales force
because new recruits may obtain the requisite licenses at rates above or below
historical levels.

The size of the life-licensed independent sales force was as follows:

March 31, 2020       December 31, 

2019


Life-licensed sales representatives            130,095                 

130,522




Details on new recruits and life-licensed sales representative activity were as
follows:

                                             Three months ended March 31,
                                               2020                 2019
New recruits                                      84,762               63,223
New life-licensed sales representatives           10,599               10,065




                                       26

--------------------------------------------------------------------------------


New recruits increased during the three months ended March 31, 2020 compared to
the same period in 2019 due to positive recruiting momentum generated in recent
periods combined with the effect of offering discounted business application
fees in early January and again at the end of March to sustain our recruiting
momentum as COVID-19 concerns began to emerge. New life-licensed representatives
increased during the three months ended March 31, 2020 compared to the same
period in 2019 due to strength in recruiting despite licensing headwinds related
to the COVID-19 pandemic that included the suspension of live licensing
preparation classes and the closing of licensing exam centers. In order to
address challenges in life licensing presented by the COVID-19 pandemic, we have
enhanced current incentive programs that encourage recruits to get through the
licensing process, expanded the reach of online offerings for licensing exam
preparation, and worked with states to offer alternatives to the traditional
licensing process including remote testing and the issuance of temporary
licenses until the full licensing process can be completed.

Term Life Insurance Product Sales and Face Amount In Force.



The average number of life-licensed sales representatives and the number of term
life insurance policies issued, as well as the average monthly rate of new
policies issued per life-licensed sales representative (historically between
0.18 and 0.22), were as follows:

                                                       Three months ended 

March 31,


                                                        2020                

2019


Average number of life-licensed sales
representatives                                            130,106          

130,117


Number of new policies issued                               71,318          

64,242


Average monthly rate of new policies issued per
life-licensed
  sales representative                                        0.18                  0.16


New policies issued during the three months ended March 31, 2020 increased
compared to the same period in 2019 as a result of a stronger productivity,
which is measured by the average monthly rate of new policies issued per
life-licensed sales representative. Productivity increased in the current period
as a result of positive distribution momentum. We utilized existing tools to
minimize the adverse impact that COVID-19-related conditions could have on new
policy sales such as mobile and web-based applications that allow life-licensed
sales representatives to communicate with clients remotely and submit
applications electronically. Furthermore, we have leveraged the use of TermNow,
our rapidly underwritten term life product that uses database underwriting
instead of traditional medical exam information for policies with face amounts
of $300,000 or less. For new policies sales exceeding these limits, we have
identified alternative solutions to traditional methods of collecting medical
exam information such as the use of available clinical testing instead of
in-home testing. Given the time it takes to issue a policy underwritten with
medical exam information, policies issued in the first quarter of 2020 generally
are attributable to applications submitted prior to the onset of COVID-19
stay-at-home orders.

The changes in the face amount of our in-force book of term life insurance
policies were as follows:

                                                         Three months ended March 31,
                                                     % of beginning                      % of beginning
                                         2020            balance             2019            balance
                                                               (Dollars in millions)
Face amount in force, beginning of
period                                $  808,262                          $ 

781,041


Net change in face amount:
Issued face amount                        23,221                   3 %        20,925                   3 %
Terminations                             (18,294 )                (2 )%      (18,383 )                (2 )%
Foreign currency                          (8,676 )                (1 )%        1,969                   *
Net change in face amount                 (3,749 )                 *           4,511                   1 %
Face amount in force, end of period   $  804,513                          $  785,552


* Less than 1%.


The face amount of term life policies in force increased 3% as of March 31, 2020
compared to March 31, 2019 as the level of face amount issued continued to
exceed the face amount terminated. As a percentage of the beginning face amount
in force, issued face amount as well as terminated face amount during the three
months ended March 31, 2020 remained consistent with the comparable 2019 period.
During the three months ended March 31, 2020, the effect of a stronger U.S.
dollar in relation to the Canadian dollar reduced the translated face amount of
existing policies in force and reduced the overall issued face amount.
Conversely, during the three months ended March 31, 2019, the strengthening of
the Canadian dollar in relation to the U.S. dollar added to the increase in face
amount.

Investment and Savings Products Sales, Asset Values and Accounts/Positions.

Investment and savings products sales and average client asset values were as follows:





                                       27

--------------------------------------------------------------------------------



                                         Three months ended March 31,               Change
                                           2020                 2019             $           %
                                                           (Dollars in millions)
Product sales:
Retail mutual funds                   $        1,202       $          954     $   248          26 %
Annuities and other                              673                  547         126          23 %
Total sales-based revenue
generating product sales                       1,875                1,501         374          25 %
Managed investments                              246                  162          85          52 %
Segregated funds and other                       125                   94          30          32 %
Total product sales                   $        2,246       $        1,757     $   490          28 %
Average client asset values:
Retail mutual funds                   $       40,643       $       37,657     $ 2,986           8 %
Annuities and other                           19,681               18,240       1,442           8 %
Managed investments                            3,905                3,241         664          20 %
Segregated funds                               2,366                2,314          52           2 %

Total average client asset values $ 66,595 $ 61,452

  $ 5,143           8 %


* Less than 1%.



The rollforward of asset values in client accounts was as follows:



                                                                  Three 

months ended March 31,


                                                          % of beginning
                                           2020               balance            2019           % of beginning balance
                                                                      (Dollars in millions)
Asset values, beginning of period       $    70,537                           $    57,704
Net change in asset values:
Inflows                                       2,246             3 %                 1,757                 3 %
Redemptions                                  (1,704 )          (2 )%               (1,530 )              (3 )%
Net flows                                       542             *                     227                 *
Change in fair value, net                   (11,065 )         (19 )%                5,470                 9 %
Foreign currency, net                          (978 )           *                     201                 *
Net change in asset values                  (11,501 )         (20 )%                5,898                10 %
Asset values, end of period             $    59,036                           $    63,602


* Less than 1%.

Average number of fee-generating positions was as follows:



                                     Three months ended March 31,              Change
                                       2020                2019          Positions       %
                                                     (Positions in thousands)

Average number of fee-generating


  positions (1):
Recordkeeping and custodial                2,031               1,998             33       2 %
Recordkeeping only                           658                 641             18       3 %
Total average number of fee-
  generating positions                     2,689               2,639        

50 2 %

(1) We receive recordkeeping fees by mutual fund positions. An individual client

account may include multiple mutual fund positions. We may also receive

fees, which are earned on a per account basis, for custodial services that

we provide to clients with retirement plan accounts that hold positions in

these mutual funds.

Changes in Investment and Savings Products Sales, Asset Values and Accounts/Positions during the Three Months Ended March 31, 2020



Product sales. Investment and savings products sales increased during the three
months ended March 31, 2020 compared to the three months ended March 31, 2019
due to a combination of strong demand for variable annuity products and mutual
funds and, to a lesser degree, higher sales of managed accounts, that followed a
prolonged period of strong equity market performance leading into early 2020. In
contrast, the period ended March 31, 2019 was preceded by a market correction in
December 2018 that weakened demand for investment and saving products. We did
not experience an adverse impact to demand for the investments and savings
products we distribute as a result of the economic downturn associated with the
COVID-19 pandemic as these events occurred late in the quarter.

Average client asset values. Average client asset values increased during the
three months ended March 31, 2020 compared to the three months ended March 31,
2019 primarily due to market appreciation between the periods and continued
positive net flows, partially offset by poor market performance at the end of
the quarter as a result of the market reaction and economic uncertainty
associated with the COVID-19 pandemic.

Rollforward of client asset values. The decrease in client asset values for the
three months ended March 31, 2020 compared to the three months ended March 31,
2019 was primarily due to the significant decline in the value of client assets
stemming from



                                       28

--------------------------------------------------------------------------------


market reaction and economic uncertainty associated with the COVID-19 pandemic.
Partially offsetting the decline in client asset values was positive net flows
driven by strong product sales during the quarter. Redemptions for the quarter
grew in-line with client asset values.

Average number of fee-generating positions. The average number of fee-generating
positions increased during the three months ended March 31, 2020 compared to the
three months ended March 31, 2019 primarily due to the cumulative effect of
retail mutual fund sales in recent periods that led to an increase in the number
of retail mutual fund positions serviced on our transfer agent record keeping
platform.

Other business trends and conditions.



Standards of care. On June 5, 2019, the SEC adopted rules and interpretations
addressing the standards of conduct applicable to broker-dealers and investment
advisers and their associated persons (collectively, the "SEC
Rulemaking"). Specifically, the SEC Rulemaking (i) creates a new "best interest"
standard of conduct for broker-dealers ("Reg BI"), (ii) imposes new disclosure
requirements through summary forms intended to clarify relationships among
brokers, advisers, and their retail customers ("Form CRS"), (iii) provides
interpretative guidance regarding the standard of conduct that applies to
investment advisers under the Investment Advisers Act of 1940 ("Advisers Act'),
and (iv) provides interpretative guidance on the scope of the broker-dealer
"solely incidental" exclusion from the definition of "investment adviser" in the
Advisers Act. The SEC Rulemaking became effective on July 12, 2019, with a
compliance date of June 30, 2020 for Reg BI and Form CRS. We anticipate making
certain changes to our sales processes, policies, and procedures in order to
comply with the SEC Rulemaking. While we acknowledge that its higher standards
of care and enhanced obligations increase regulatory and litigation risk, we do
not anticipate that the SEC Rulemaking will cause significant disruption to our
business.

Certain states have proposed or passed laws or proposed or issued regulations
requiring investment advisers, broker-dealers, and/or insurance agents to meet
fiduciary standards or standards of care that their advice be in the customer's
best interest, and to mitigate and disclose conflicts of interest to consumers
of investment and insurance products. The severity of the impact that such state
laws or regulations could have on our business vary from state to state
depending on the content of the legislation or regulation and how it would be
applied by state regulators and interpreted by the courts, but any such laws or
regulations could disrupt our brokerage business in the relevant state. We
cannot quantify the financial impact, if any, of any changes to our business
that may be necessary in order to comply with such laws or regulations at this
time.



Restriction on compensation models in Canada. The organization of provincial and
territorial securities regulators (collectively referred to as the "Canadian
Securities Administrators" or "CSA") published final rule amendments, applicable
in all provinces except Ontario, to prohibit upfront sales commissions by fund
companies for the sale of mutual funds offered under a prospectus in Canada
effective June 1, 2022 ("DSC Ban"). The CSA indicated that the participating
provinces' prohibition of upfront sales commissions by fund companies will
require firms to discontinue the use of the mutual fund deferred sales charge
compensation model, which is the primary model for the mutual funds we
distribute in Canada.  These rules will result in changes in compensation
arrangements with both the fund companies that offer the mutual fund products we
distribute and sales representatives in the participating provinces. The
deferred sales charge compensation model is permitted to be used until the
effective date. While Ontario has disagreed with the prohibition of upfront
sales commissions by fund companies and is not at this time participating in
adoption of the DSC Ban, the Ontario Securities Commission has proposed several
restrictions effective June 1, 2022 on the use of the deferred compensation
model, including a $50,000 maximum account size and a limitation on the maximum
term of the deferred sales charge schedule to three years compared to current
industry practice where the maximum term can be up to seven years. We have not
finished the process of determining the types of changes we will make in
response to the DSC Ban and the restrictions in Ontario, therefore, we are
unable to quantify the potential impact on our financial condition or results of
operations.



Factors Affecting Our Results

Refer to the Business Trends and Conditions section for discussion of the potential impact on our business from the COVID-19 pandemic.

Term Life Insurance Segment. Our Term Life Insurance segment results are primarily driven by sales volumes, how closely actual experience matches our pricing assumptions, terms and use of reinsurance, and expenses.



Sales and policies in force. Sales of term policies and the size and
characteristics of our in-force book of policies are vital to our results over
the long term. Premium revenue is recognized as it is earned over the term of
the policy, and eligible acquisition expenses are deferred and amortized ratably
with the level premiums of the underlying policies. However, because we incur
significant cash outflows at or about the time policies are issued, including
the payment of sales commissions and underwriting costs, changes in life
insurance sales volume in a period will have a more immediate impact on our cash
flows than on revenue and expense recognition in that period.

Historically, we have found that while sales volume of term life insurance
products between fiscal periods may vary based on a variety of factors, the
productivity of sales representatives generally remains within a range (i.e., an
average monthly rate of new policies issued per life-licensed sales
representative between 0.18 and 0.22). The volume of our term life insurance
products sales will fluctuate in the short-term, but over the longer term, our
sales volume generally correlates to the size of the independent sales force.



                                       29

--------------------------------------------------------------------------------


Pricing assumptions. Our pricing methodology is intended to provide us with
appropriate profit margins for the risks we assume. We determine pricing
classifications based on the coverage sought, such as the size and term of the
policy, and certain policyholder attributes, such as age and health. In
addition, we generally utilize unisex rates for our term life insurance
policies. The pricing assumptions that underlie our rates are based upon our
best estimates of mortality, persistency, disability, and interest rates at the
time of issuance, sales force commission rates, issue and underwriting expenses,
operating expenses and the characteristics of the insureds, including the
distribution of sex, age, underwriting class, product and amount of coverage.
Our results will be affected to the extent there is a variance between our
pricing assumptions and actual experience.

• Persistency. Persistency is a measure of how long our insurance policies


        stay in force. As a general matter, persistency that is lower than our
        pricing assumptions adversely affects our results over the long term

because we lose the recurring revenue stream associated with the policies

that lapse. Determining the near-term effects of changes in persistency is

more complicated. When actual persistency is lower than our pricing

assumptions, we must accelerate the amortization of deferred policy

acquisition costs ("DAC"). The resultant increase in amortization expense

is offset by a corresponding release of reserves associated with lapsed


        policies, which causes a reduction in benefits and claims expense. The
        future policy benefit reserves associated with any given policy will

change over the term of such policy. As a general matter, future policy


        benefit reserves are lowest at the inception of a policy term and rise
        steadily to a peak before declining to zero at the expiration of the

policy term. Accordingly, depending on when the lapse occurs in relation

to the overall policy term, the reduction in benefits and claims expense

may be greater or less than the increase in amortization expense, and,

consequently, the effects on earnings for a given period could be positive

or negative. Persistency levels will impact results to the extent actual

experience deviates from the persistency assumptions that are locked-in at

time of issue.

• Mortality. Our profitability will fluctuate to the extent actual mortality

rates differ from the assumptions that are locked-in at time of issue. We


        mitigate a significant portion of our mortality exposure through
        reinsurance.


    •   Disability. Our profitability will fluctuate to the extent actual

disability rates, including recovery rates for individuals currently

disabled, differ from the assumptions that are locked-in at the time of

issue or time of disability.

• Interest Rates. We use an assumption for future interest rates that

initially reflects the current low interest rate environment gradually

increasing to a level consistent with historical experience. Both DAC and

the future policy benefit reserve liability increase with the assumed

interest rate. Since DAC is higher than the future policy benefit reserve


        liability in the early years of a policy, a lower assumed interest rate
        generally will result in lower profits. In the later years, when the
        future policy benefit reserve liability is higher than DAC, a lower
        assumed interest rate generally will result in higher profits. These

assumed interest rates, which like other pricing assumptions are locked-in

at issue, impact the timing but not the aggregate amount of DAC and future

policy benefit reserve changes. We allocate net investment income

generated by the investment portfolio to the Term Life Insurance segment

in an amount equal to the assumed net interest accreted to the segment's

U.S. generally accepted accounting principles ("U.S. GAAP")-measured

future policy benefit reserve liability less DAC. All remaining net

investment income, and therefore the impact of actual interest rates, is

attributed to the Corporate and Other Distributed Products segment.




Reinsurance. We use reinsurance extensively, which has a significant effect on
our results of operations. We have generally reinsured between 80% and 90% of
the mortality risk on our term life insurance (excluding coverage under certain
riders) on a quota share yearly renewable term ("YRT") basis. To the extent
actual mortality experience is more or less favorable than the contractual rate,
the reinsurer will earn incremental profits or bear the incremental cost, as
applicable. In contrast to coinsurance, which is intended to eliminate all risks
(other than counterparty risk of the reinsurer) and rewards associated with a
specified percentage of the block of policies subject to the reinsurance
arrangement, the YRT reinsurance arrangements we enter into are intended only to
reduce volatility associated with variances between estimated and actual
mortality rates.

In 2010, as part of our corporate reorganization and the initial public offering
of our common stock, we entered into significant coinsurance transactions (the
"IPO coinsurance transactions") with entities then affiliated with Citigroup,
Inc. (collectively, the "IPO coinsurers") and ceded between 80% and 90% of the
risks and rewards of our term life insurance policies that were in force at
year-end 2009. We administer all such policies subject to these coinsurance
agreements. Policies reaching the end of their initial level term period are no
longer ceded under the IPO coinsurance transactions.

The effect of our reinsurance arrangements on ceded premiums and benefits and expenses on our statement of income follows:

• Ceded premiums. Ceded premiums are the premiums we pay to reinsurers.

These amounts are deducted from the direct premiums we earn to calculate

our net premium revenues. Similar to direct premium revenues, ceded

coinsurance premiums remain level over the initial term of the insurance


        policy. Ceded YRT premiums increase over the period that the policy has
        been in force. Accordingly, ceded YRT premiums generally constitute an
        increasing percentage of direct premiums over the policy term.

• Benefits and claims. Benefits and claims include incurred claim amounts

and changes in future policy benefit reserves. Reinsurance reduces

incurred claims in direct proportion to the percentage ceded. Coinsurance


        also reduces the change in future policy benefit reserves in direct
        proportion to the percentage ceded, while YRT reinsurance does not
        significantly impact the change in these reserves.




                                       30

--------------------------------------------------------------------------------

• Amortization of DAC. DAC, and therefore amortization of DAC, is reduced on

a pro-rata basis for the coinsured business, including the business

reinsured with the IPO coinsurers. There is no impact on amortization of

DAC associated with our YRT contracts.

• Insurance expenses. Insurance expenses are reduced by the allowances

received from coinsurance. There is no impact on insurance expenses

associated with our YRT contracts.




We may alter our reinsurance practices at any time due to the unavailability of
YRT reinsurance at attractive rates or the availability of alternatives to
reduce our risk exposure. We presently intend to continue ceding approximately
90% of our U.S. and Canadian mortality risk on new business.

Expenses. Results are also affected by variances in client acquisition, maintenance and administration expense levels.



Investment and Savings Products Segment. Our Investment and Savings Products
segment results are primarily driven by sales, the value of assets in client
accounts for which we earn ongoing management, marketing and support, and
distribution fees, and the number of transfer agent recordkeeping positions and
non-bank custodial fee-generating accounts we administer.

Sales. We earn commissions and fees, such as dealer re-allowances and marketing
and distribution fees, based on sales of mutual fund products and annuities.
Sales of investment and savings products are influenced by the overall demand
for investment products in the United States and Canada, as well as by the size
and productivity of the independent sales force. We generally experience
seasonality in our Investment and Savings Products segment results due to our
high concentration of sales of retirement account products. These accounts are
typically funded in February through April, coincident with our clients' tax
return preparation season. While we believe the size of the independent sales
force is a factor in driving sales volume in this segment, there are a number of
other variables, such as economic and market conditions, which may have a
significantly greater effect on sales volume in any given fiscal period.

Asset values in client accounts. We earn marketing and distribution fees (trail
commissions or, with respect to U.S. mutual funds, 12b-1 fees) on mutual fund
and annuity assets in the United States and Canada. In the United States, we
also earn investment advisory and administrative fees on assets in managed
investments. In Canada, we earn management fees on certain mutual fund assets
and on the segregated funds for which we serve as investment manager. Asset
values are influenced by new product sales, ongoing contributions to existing
accounts, redemptions and the change in market values in existing accounts.
While we offer a wide variety of asset classes and investment styles, our
clients' accounts are primarily invested in equity funds.

Positions. We earn transfer agent recordkeeping fees for administrative
functions we perform on behalf of several of our mutual fund providers. An
individual client account may include multiple fund positions for which we earn
transfer agent recordkeeping fees. We may also receive fees earned for non-bank
custodial services that we provide to clients with retirement plan accounts.

Sales mix. While our investment and savings products all provide similar long-term economic returns to the Company, our results in a given fiscal period will be affected by changes in the overall mix of products within these categories. Examples of changes in the sales mix that influence our results include the following:

• sales of annuity products in the United States will generate higher

revenues in the period such sales occur than sales of other investment

products that either generate lower upfront revenues or, in the case of

managed investments and segregated funds, no upfront revenues;

• sales of a higher proportion of managed investments and segregated funds


        products will spread the revenues generated over time because we earn
        higher revenues based on assets under management for these accounts each

period as opposed to earning upfront revenues based on product sales; and

• sales of a higher proportion of mutual fund products sold will impact the

timing and amount of revenue we earn given the distinct transfer agent

recordkeeping and non-bank custodial services we provide for certain

mutual fund products we distribute.




Corporate and Other Distributed Products Segment. We earn revenues and pay
commissions and referral fees within our Corporate and Other Distributed
Products segment for various other insurance products, prepaid legal services
and other financial products, all of which are originated by third parties. Our
Corporate and Other Distributed Products segment also includes in-force policies
from several discontinued lines of insurance underwritten by NBLIC.

Corporate and Other Distributed Products segment net investment income reflects
actual net investment income recognized by the Company less the amount allocated
to our Term Life Insurance segment based on the assumed net interest accreted to
the segment's U.S. GAAP-measured future policy benefit reserve liability less
DAC. Actual net investment income reflected in the Corporate and Other
Distributed Products segment is impacted by the size and performance of our
invested asset portfolio, which can be influenced by interest rates, credit
spreads, and the mix of invested assets.

The Corporate and Other Distributed Products segment also includes corporate
income and expenses not allocated to our other segments, general and
administrative expenses (other than expenses that are allocated to our Term Life
Insurance or Investment and Savings Products segments), interest expense on
notes payable, redundant reserve financing transactions and our revolving credit
facility, as well as realized gains and losses on our invested asset portfolio.



                                       31

--------------------------------------------------------------------------------


Capital Structure. Our financial results are affected by our capital structure,
which includes our senior unsecured notes (the "Senior Notes"), redundant
reserve financing transactions, our revolving credit facility, and our common
stock. See Note 7 (Stockholders' Equity), Note 10 (Commitments and Contingent
Liabilities), and Note 12 (Debt) to our unaudited condensed consolidated
financial statements included elsewhere in this report for more information on
changes in our capital structure.

Foreign Currency. The Canadian dollar is the functional currency for our
Canadian subsidiaries and our consolidated financial results, reported in U.S.
dollars, are affected by changes in the currency exchange rate. As such, the
translated amount of revenues, expenses, assets and liabilities attributable to
our Canadian subsidiaries will be higher or lower in periods where the Canadian
dollar appreciates or weakens relative to the U.S. dollar, respectively. See
Item 7A. Quantitative and Qualitative Disclosures About Market Risk - Canadian
Currency Risk included in our 2019 Annual Report and Note 2 (Segment and
Geographical Information) to our unaudited condensed consolidated financial
statements included elsewhere in this report for more information on our
Canadian subsidiaries and the impact of foreign currency on our financial
results.



Critical Accounting Estimates



We prepare our financial statements in accordance with U.S. GAAP. These
principles are established primarily by the Financial Accounting Standards
Board. The preparation of financial statements in conformity with U.S. GAAP
requires us to make estimates and assumptions based on currently available
information when recording transactions resulting from business operations. Our
significant accounting policies are described in Note 1 (Description of
Business, Basis of Presentation, and Summary of Significant Accounting Policies)
to our consolidated financial statements included in our 2019 Annual Report. The
most significant items on our condensed consolidated balance sheets are based on
fair value determinations, accounting estimates and actuarial determinations,
which are susceptible to changes in future periods and could affect our results
of operations and financial position.

The estimates that we deem to be most critical to an understanding of our
results of operations and financial position are those related to DAC, future
policy benefit reserves and corresponding amounts recoverable from reinsurers,
income taxes, and the valuation of investments. The preparation and evaluation
of these critical accounting estimates involve the use of various assumptions
developed from management's analyses and judgments. Subsequent experience or use
of other assumptions could produce significantly different results.

Accounting Policy Changes. On January 1, 2020, the Company adopted Accounting
Standards Update No. 2016-13, Financial Instruments-Credit Losses (Topic 326) -
Measurement of Credit Losses on Financial Instruments ("ASC 326"). ASC 326
maintains the fundamental incurred probable loss approach for measuring losses
in the condensed consolidated statement of income and replaces the
other-than-temporary impairment model with a subtly different credit loss model.
For available-for-sale securities in an unrealized loss position that we intend
to sell or would more-likely-than-not be required to sell before the expected
recovery of the amortized cost basis, we still recognize the impairment in our
condensed consolidated statements of income by writing down the amortized cost
basis to the fair value under ASC 326. For available-for-sale securities in an
unrealized loss position that we do not intend to sell or it is not
more-likely-than-not that we will be required to sell before the expected
recovery of the amortized cost basis, ASC 326 requires that we recognize the
portion of the impairment that is due to a credit loss in our condensed
consolidated statements of income through an allowance. We are allowed to
reverse credit losses previously recognized in the allowance in situations where
the estimate of credit losses on those securities has declined. The amendments
in ASC 326 also preclude us from considering the length of time an
available-for-sale security has been in an unrealized loss position and removes
the requirement to consider recoveries or declines in fair value after the
balance sheet date when determining whether an impairment on a security is due
to a credit loss. The adoption of ASC 326 has not resulted in any material
changes to impairment losses recognized in our condensed consolidated statements
of income for available-for-sale securities.

During the three months ended March 31, 2020, there have been no changes in the
accounting methodology for items that we have identified as critical accounting
estimates. For additional information regarding our critical accounting
estimates, see the Critical Accounting Estimates section of MD&A included in our
2019 Annual Report.



                                       32

--------------------------------------------------------------------------------



Results of Operations



Primerica, Inc. and Subsidiaries Results. Our results of operations were as
follows:

                                          Three months ended March 31,                Change
                                             2020                2019             $             %
                                                           (Dollars in thousands)
Revenues:
Direct premiums                         $       702,637       $   677,286     $   25,351            4 %
Ceded premiums                                 (386,825 )        (389,795 )       (2,970 )         (1 )%
Net premiums                                    315,812           287,491         28,321           10 %
Commissions and fees                            190,069           167,315         22,754           14 %
Investment income net of investment
expenses                                         28,892            34,785         (5,893 )        (17 )%
Interest expense on surplus note                (13,472 )         (10,674 )        2,798           26 %
Net investment income                            15,420            24,111         (8,691 )        (36 )%
Realized investment gains (losses)              (10,030 )           2,847        (12,877 )          *
Other, net                                       13,665            13,223            442            3 %
Total revenues                                  524,936           494,987         29,949            6 %

Benefits and expenses:
Benefits and claims                             134,813           122,284         12,529           10 %
Amortization of DAC                              70,311            64,628          5,683            9 %
Sales commissions                                96,607            83,799         12,808           15 %
Insurance expenses                               48,709            43,402          5,307           12 %
Insurance commissions                             6,844             5,619          1,225           22 %
Interest expense                                  7,192             7,180             12            *
Other operating expenses                         65,914            65,707            207            *
Total benefits and expenses                     430,390           392,619         37,771           10 %
Income before income taxes                       94,546           102,368         (7,822 )         (8 )%
Income taxes                                     22,077            23,203         (1,126 )         (5 )%
Net income                              $        72,469       $    79,165     $   (6,696 )         (8 )%

* Less than 1% or not meaningful.

Results for the Three Months Ended March 31, 2020





Total revenues. Total revenues increased during the three months ended March 31,
2020 compared to the same period in 2019 driven by incremental premiums on term
life insurance policies that are not subject to the IPO coinsurance
transactions. The run-off of business subject to these same transactions is
reflected in the decline in ceded premiums. Commissions and fees from our
Investment and Savings Products segment increased largely due to growth in
product sales and higher average client asset values in 2020 as compared to
2019.

Net investment income decreased during the three months ended March 31, 2020
compared to the same period in 2019 largely due to the negative impact from a
lower total return on the deposit asset backing the 10% coinsurance agreement
that is subject to deposit method accounting. The lower total return of $8.5
million on this deposit asset was primarily due to a negative mark-to-market
adjustment as fixed income security prices fell during the current year period
as a result of economic uncertainty associated with the COVID-19 pandemic. Also
contributing to a decrease in net investment income was lower yield on our
invested portfolio of approximately $2.1 million, partially offset by larger
invested asset portfolio which resulted in an increase in net investment income
of approximately $1.8 million compared to the prior period. Investment income
net of investment expenses includes interest earned on our held-to-maturity
invested asset, which is completely offset by interest expense on surplus note,
thereby eliminating any impact on net investment income. Amounts recognized for
each line item will remain offsetting and will fluctuate from period to period
along with the principal amounts of the held-to-maturity asset and the surplus
note based on the balance of reserves being contractually supported under a
redundant reserve financing transaction used by Vidalia Re, Inc. ("Vidalia Re
Financing Transaction"). For more information on the Vidalia Re Financing
Transaction, see Note 3 (Investments) and Note 12 (Debt) to our unaudited
condensed consolidated financial statements included elsewhere in this report.

Realized investment gains (losses) during the three months ended March 31, 2020
was a loss compared to a gain in the same period in 2019 primarily due to $6.7
million negative mark-to-market adjustment on equity securities held within our
investment portfolio as a result of market reaction to the economic disruption
caused by the COVID-19 pandemic. Also contributing to the realized investment
loss in the current period is the recognition of $3.7 million of credit losses
for specific issuers that operate in distressed industry sectors that were
particularly affected by deteriorating credit conditions during the three months
ended March 31, 2020.

Total benefits and expenses. Total benefits and expenses increased during the
three months ended March 31, 2020 compared to the three months ended March 31,
2019 led by growth in premium-related costs, which include benefits and claims
and amortization of DAC. Sales commissions expense also increased in the three
months ended March 31, 2020 versus the three months ended March 31,



                                       33

--------------------------------------------------------------------------------

2019 due to increased commissions and fees revenue. Insurance expenses were higher due to increases in expenses to support growth in the business and to enhance technology-related capabilities.



Income taxes. Our effective income tax rate for the three months ended March 31,
2020 was 23.4%, compared to 22.7% for the three months ended March 31, 2019 due
to lower tax benefits recognized in the current period on equity award vesting
compared to the same period in 2019. Tax benefits recognized on equity awards
include increases in the share price of equity awards from the grant date to the
vest date and such increases were lower in 2020 as compared with 2019.

For additional information, see the Segment Results discussions below.

Segment Results



Term Life Insurance Segment Results. Our results for the Term Life Insurance
segment were as follows:

                                Three months ended March 31,             Change
                                   2020                2019            $          %
                                              (Dollars in thousands)
Revenues:
Direct premiums               $       696,564       $   670,755     $ 25,809        4 %
Ceded premiums                       (385,232 )        (388,100 )     (2,868 )     (1 )%
Net premiums                          311,332           282,655       28,677       10 %
Allocated investment income             6,246             4,444        1,802       41 %
Other, net                             10,168             9,744          424        4 %
Total revenues                        327,746           296,843       30,903       10 %
Benefits and expenses:
Benefits and claims                   128,563           118,443       10,120        9 %
Amortization of DAC                    65,840            64,066        1,774        3 %
Insurance expenses                     47,165            41,832        5,333       13 %
Insurance commissions                   3,286             2,163        1,123       52 %
Total benefits and expenses           244,854           226,504       

18,350 8 % Income before income taxes $ 82,892 $ 70,339 $ 12,553 18 %

Results for the Three Months Ended March 31, 2020



Net premiums. Direct premiums increased during the three months ended March 31,
2020 compared to the three months ended March 31, 2019 largely due to sales of
new policies in recent periods that have contributed to growth in the in-force
book of business. The decline in ceded premiums includes $13.3 million in lower
coinsurance ceded premiums due to the run-off of business subject to the IPO
coinsurance transactions, partially offset by $10.4 million in higher non-level
YRT reinsurance ceded premiums as business not subject to the IPO coinsurance
transactions ages. The continued impact from the increase of direct premiums
combined with the reduction in ceded premiums caused net premiums to grow at a
higher rate than direct premiums.

Allocated investment income. Allocated investment income increased during the
three months ended March 31, 2020 compared to the three months ended March 31,
2019 due to an increase in the assumed net interest accreted to our Term Life
Insurance segment's future policy benefit reserve liability less deferred
acquisition costs as our Term Life Insurance segment's in-force business
continues to grow.

Benefits and claims. Benefits and claims increased during the three months ended
March 31, 2020 compared to the same period in 2019 primarily due to the growth
in net premiums. Claims experience was in line with historical trends.

Amortization of DAC. The amortization of DAC increased during the three months
ended March 31, 2020 compared to the three months ended March 31, 2019 largely
due to growth in net premiums during the first quarter of 2020 compared to the
same period in 2019. The rate of growth in DAC is lower than the premium growth
due to the impact of favorable trends in persistency in recent periods.

Insurance expenses. Insurance expenses increased during the three months ended
March 31, 2020 compared to the three months ended March 31, 2019 primarily due
to increases in expenses to support growth in the business and to enhance
technology-related capabilities.

Insurance commissions. Insurance commissions increased during the three months ended March 31, 2020 compared to the three months ended March 31, 2019 as a result of higher non-deferrable sales force promotional activities.

Investment and Savings Products Segment Results. Investment and Savings Products segment results were as follows:







                                       34

--------------------------------------------------------------------------------



                                Three months ended March 31,               Change
                                  2020                 2019             $           %
                                                 (Dollars in thousands)
Revenues:
Commissions and fees:
Sales-based revenues         $       80,891       $       66,997     $ 13,894        21 %
Asset-based revenues                 81,395               73,639        7,756        11 %
Account-based revenues               20,204               19,613          591         3 %
Other, net                            2,542                2,423          119         5 %
Total revenues                      185,032              162,672       22,360        14 %
Expenses:
Amortization of DAC                   4,305                  477        3,828       803 %
Insurance commissions                 3,201                3,025          176         6 %
Sales commissions:
Sales-based                          56,561               47,831        8,730        18 %
Asset-based                          36,323               32,343        3,980        12 %
Other operating expenses             36,942               36,312          630         2 %
Total expenses                      137,332              119,988       17,344        14 %
Income before income taxes   $       47,700       $       42,684     $  5,016        12 %



Results for the Three Months Ended March 31, 2020



Commissions and fees. Commissions and fees increased during the three months
ended March 31, 2020 compared to the three months ended March 31, 2019 driven by
higher demand for mutual fund products and variable annuity products. Also
contributing to the increase in commissions and fees was growth in asset-based
revenues as average client asset values increased in 2020 versus 2019 due to
market performance and continued positive net flows between the two periods. The
impact of the significant decline in investment markets during the first quarter
of 2020 on average client asset values was limited as the decline occurred
during the final month of the three months ended March 31, 2020.

Amortization of DAC. Amortization of DAC increased during the three months ended
March 31, 2020 compared to the three months ended March 31, 2019 largely due to
a negative market performance of the funds underlying our Canadian segregated
funds product caused by market conditions and economic uncertainty associated
with the COVID-19 pandemic in 2020 compared with positive market performance in
2019.

Sales commissions. The increase in sales-based and asset-based commissions for
the three months ended March 31, 2020 compared to the three months ended March
31, 2019 were generally consistent with the increase in sales-based revenue and
asset-based revenue, respectively.

Other operating expenses. Other operating expenses increased during the three
months ended March 31, 2020 compared to the three months ended March 31, 2019
due to increased spending on technology-related expenses, partially offset by
the phase-in of reduced fees paid to a service provider for the Company's
transfer agent recordkeeping platform.

Corporate and Other Distributed Products Segment Results. Corporate and Other Distributed Products segment results were as follows:


                                       35

--------------------------------------------------------------------------------



                                           Three months ended March 31,                Change
                                             2020                 2019              $            %
                                                           (Dollars in thousands)
Revenues:
Direct premiums                         $        6,073       $        6,531     $    (458 )        (7 )%
Ceded premiums                                  (1,593 )             (1,695 )        (102 )        (6 )%
Net premiums                                     4,480                4,836          (356 )        (7 )%
Commissions and fees                             7,579                7,066           513           7 %
Investment income net of investment
expenses                                        22,646               30,341        (7,695 )       (25 )%
Interest expense on surplus note               (13,472 )            (10,674 )       2,798          26 %
Net investment income                            9,174               19,667       (10,493 )       (53 )%
Realized investment gains (losses)             (10,030 )              2,847       (12,877 )         *
Other, net                                         955                1,056          (101 )       (10 )%
Total revenues                                  12,158               35,472       (23,314 )       (66 )%
Benefits and expenses:
Benefits and claims                              6,250                3,841         2,409          63 %
Amortization of DAC                                166                   85            81          95 %
Insurance expenses                               1,544                1,570           (26 )        (2 )%
Insurance commissions                              357                  431           (74 )       (17 )%
Sales commissions                                3,723                3,625            98           3 %
Interest expense                                 7,192                7,180            12           *
Other operating expenses                        28,972               29,395          (423 )        (1 )%
Total benefits and expenses                     48,204               46,127         2,077           5 %
Loss before income taxes                $      (36,046 )     $      (10,655 )   $  25,391         238 %

* Less than 1% or not meaningful.

Results for the Three Months Ended March 31, 2020



Total revenues. Total revenues decreased during the three months ended March 31,
2020 compared to the three months ended March 31, 2019 largely due to the
decrease in net investment income and realized investment gains (losses) as
discussed in the Primerica, Inc. and Subsidiaries Results of Operations section
above.

Total benefits and expenses. Total benefits and expenses increased during the
three months ended March 31, 2020 compared to the three months ended March 31,
2019 primarily due to higher benefits and claims experienced on non-term life
insurance business underwritten by NBLIC and the recognition of a $1.6 million
allowance for ceded claims on a closed block of business that may not be
collected from a reinsurer that was ordered into receivership.

Financial Condition



Investments. Our insurance business is primarily focused on selling term life
insurance, which does not include an investment component for the policyholder.
The invested asset portfolio funded by premiums from our term life insurance
business does not involve the substantial asset accumulations and spread
requirements that exist with other non-term life insurance products. As a
result, the profitability of our term life insurance business is not as
sensitive to the impact that interest rates have on our invested asset portfolio
and investment income as the profitability of other companies that distribute
non-term life insurance products.

We follow a conservative investment strategy designed to emphasize the
preservation of our invested assets and provide adequate liquidity for the
prompt payment of claims. To meet business needs and mitigate risks, our
investment guidelines provide restrictions on our portfolio's composition,
including limits on asset type, per issuer limits, credit quality limits,
portfolio duration, limits on the amount of investments in approved countries
and permissible security types. We also manage and monitor our allocation of
investments to limit the accumulation of any disproportionate concentrations of
risk among industry sectors or issuer countries outside of the U.S. and Canada.
In addition, as of March 31, 2020, we did not hold any country of issuer
concentrations outside of the U.S. or Canada that represented more than 5% of
the fair value of our available-for-sale invested asset portfolio or any
industry concentrations of corporate bonds that represented more than 10% of the
fair value of our available-for-sale invested asset portfolio.

We invest a portion of our portfolio in assets denominated in Canadian dollars
to support our Canadian operations. Additionally, to ensure adequate liquidity
for payment of claims, we take into account the maturity and duration of our
invested asset portfolio and our general liability profile.

We also hold within our invested asset portfolio a credit enhanced note ("LLC
Note") issued by a limited liability company owned by a third-party service
provider which is classified as a held-to-maturity security. The LLC Note, which
is scheduled to mature on December 31, 2030, was obtained in exchange for the
Surplus Note of equal principal amount issued by Vidalia Re. For more
information on the LLC Note, see Note 3 (Investments) to our unaudited condensed
consolidated financial statements included elsewhere in this report.



                                       36

--------------------------------------------------------------------------------


We have an investment committee composed of members of our senior management
team that is responsible for establishing and maintaining our investment
guidelines and supervising our investment activity. Our investment committee
regularly monitors our overall investment results and our compliance with our
investment objectives and guidelines. We use a third-party investment advisor to
assist us in the management of our investing activities. Our investment advisor
reports to our investment committee.

Our invested asset portfolio is subject to a variety of risks, including risks
related to general economic conditions, market volatility, interest rate
fluctuations, liquidity risk and credit and default risk. Investment guideline
restrictions have been established to minimize the effect of these risks but may
not always be effective due to factors beyond our control. Interest rates and
credit spreads are highly sensitive to many factors, including governmental
monetary policies, domestic and international economic and political conditions
and other factors beyond our control. A significant increase in interest rates
or credit spreads could result in significant losses, realized or unrealized, in
the value of our invested asset portfolio. For example, from December 31, 2019
to March 31, 2020 market volatility and economic uncertainty associated with the
COVID-19 pandemic caused a sharp increase in credit spreads, which translated to
a reduction in the net unrealized gain on available-for-sale securities
portfolio from $82.2 million to a net unrealized loss of $1.3
million. Additionally, with respect to some of our investments, we are subject
to prepayment and, therefore, reinvestment risk.

Details on asset mix (excluding our held-to-maturity security) were as follows:



                                               March 31, 2020       December 31, 2019
Average rating of our fixed-maturity
portfolio                                             A                     A
Average duration of our fixed-maturity
portfolio                                         3.6 years              3.6 years
Average book yield of our fixed-maturity
portfolio                                           3.55%                 

3.54%

The distribution of our investments in fixed-maturity securities (excluding our held-to-maturity security) by rating, including those classified as trading securities, were as follows:



                                 March 31, 2020                   December 31, 2019
                          Amortized cost (1)        %        Amortized cost (1)        %
                                              (Dollars in thousands)
AAA                      $            524,942        23 %   $            555,640        24 %
AA                                    277,247        12 %                271,936        12 %
A                                     523,598        23 %                543,351        23 %
BBB                                   889,352        39 %                885,497        38 %
Below investment grade                 70,045         3 %                 59,190         3 %
Not rated                               3,101         *                    2,389         *
Total                    $          2,288,285       100 %   $          2,318,003       100 %



(1) Includes trading securities at fair value and available-for-sale securities


    at amortized cost.


* Less than 1%.


The ten largest holdings within our fixed-maturity invested asset portfolio (excluding our held-to-maturity security) were as follows:



                                                                   March 31, 2020
                                                              Amortized         Unrealized       Credit
Issuer                                       Fair value        cost (1)        gain (loss)       rating
                                                               (Dollars in thousands)
Government of Canada                         $    19,286     $     18,625     $          661       AAA
Province of Ontario Canada                        13,191           12,552                639       A+
Province of Quebec Canada                         12,913           11,787              1,126       AA-
Wells Fargo & Co                                  11,376           11,702               (326 )     A-
Enbridge Inc                                      10,681           10,876               (195 )     A+
Cigna Corp                                        10,414           10,192                222       A-
Bank of America Corp                              10,095            9,822                273       A-
Province of British Columbia Canada               10,093            9,729                364       AAA
Province of Alberta Canada                         9,984            9,538                446       A+
Province of New Brunswick Canada                   9,180            8,790                390       A+
Total - ten largest holdings                 $   117,213     $    113,613     $        3,600
Total - fixed-maturity securities            $ 2,287,034     $  2,288,285
Percent of total fixed-maturity securities             5 %              5 %




(1) Includes trading securities at fair value and available-for-sale securities

at amortized cost.

For additional information on our invested asset portfolio, see Note 3 (Investments) to our unaudited condensed consolidated financial statements included elsewhere in this report.


                                       37

--------------------------------------------------------------------------------

Liquidity and Capital Resources



Dividends and other payments to the Parent Company from its subsidiaries are our
principal sources of cash. The amount of dividends paid by the subsidiaries is
dependent on their capital needs to fund future growth and applicable regulatory
restrictions. The primary uses of funds by the Parent Company include the
payments of stockholder dividends, interest on notes payable, general operating
expenses, and income taxes, as well as repurchases of common shares outstanding.
As of March 31, 2020, the Parent Company had cash and invested assets of $271.8
million.

The Parent Company's subsidiaries generate operating cash flows primarily from
term life insurance premiums (net of premiums ceded to reinsurers), income from
invested assets, commissions and fees collected from the distribution of
investment and savings products as well as other financial products. The
subsidiaries' principal operating cash outflows include the payment of insurance
claims and benefits (net of ceded claims recovered from reinsurers), commissions
to the sales force, insurance and other operating expenses, interest expense for
future policy benefit reserves financing transactions, and income taxes.

The distribution and underwriting of term life insurance requires upfront cash
outlays at the time the policy is issued as we pay a substantial majority of the
sales commission during the first year following the sale of a policy and incur
costs for underwriting activities at the inception of a policy's term. During
the early years of a policy's term, we generally receive level term premiums in
excess of claims paid. We invest the excess cash generated during earlier policy
years in fixed-maturity and equity securities held in support of future policy
benefit reserves. In later policy years, cash received from the maturity or sale
of invested assets is used to pay claims in excess of level term premiums
received.

Historically, cash flows generated by our businesses, primarily from our
existing block of term life policies and our investment and savings products,
have provided us with sufficient liquidity to meet our operating requirements.
Although our cash flow could be adversely affected by the deteriorating economic
conditions caused by the COVID-19 pandemic, we anticipate that cash flows from
our businesses will continue to provide sufficient operating liquidity over the
next 12 months.

If necessary, we could seek to enhance our liquidity position or capital
structure through sales of our available-for-sale investment portfolio, changes
in the timing or amount of share repurchases, borrowings against our revolving
credit facility, or some combination of these sources. Additionally, we believe
that cash flows from our businesses and potential sources of funding will
sufficiently support our long-term liquidity needs.

Cash Flows. The components of the changes in cash and cash equivalents were as
follows:

                                                    Three months ended March 31,           Change
                                                     2020                  2019               $
                                                                   (In thousands)
Net cash provided by (used in) operating
activities                                      $       131,522       $       66,421     $    65,101
Net cash provided by (used in) investing
activities                                                 (744 )             25,278         (26,022 )
Net cash provided by (used in) financing
activities                                             (112,274 )            (74,987 )       (37,287 )
Effect of foreign exchange rate changes on
cash                                                     (2,295 )                776          (3,071 )
Change in cash and cash equivalents             $        16,209       $     

17,488 $ (1,279 )




Operating Activities. Cash provided by operating activities increased during the
three months ended March 31, 2020 compared to the three months ended March 31,
2019 in large part due to the impact in the prior year of reduced cash flows
caused by the timing of when cash payments to or from reinsurers were due for
ceded premiums and ceded claims. In addition, cash flows from operations
increased in 2020 due to higher cash receipts from the collection of premium
revenues in excess of benefits and claims paid in our Term Life Insurance
segment. The impact of direct premium growth and the additional layering of net
premiums from term life insurance policies not subject to the IPO coinsurance
transactions has continued to drive positive incremental cash flows from
operating activities.

Investing Activities. Cash flows related to investing activities was a slight
use of cash during the three months ended March 31, 2020 compared to a source of
cash in 2019 as a result of higher purchases of fixed maturity securities as our
invested asset portfolio has increased with the continued growth of our term
life business in force. This was partially offset due to cash receipts from the
sale and maturity of fixed-maturity securities.

Financing Activities. Cash used in financing activities increased during the
three months ended March 31, 2020 compared to the three months ended March 31,
2019 mainly due to the accelerated timing of share repurchases made in 2020 in
response to market conditions that provided an opportunity to repurchase shares
at attractive prices. In addition, the level of share repurchase activity
increased as the size of the share repurchase program in 2020 increased over
2019.

Risk-Based Capital ("RBC"). The National Association of Insurance Commissioners
("NAIC") has established RBC standards for U.S. life insurers, as well as a
risk-based capital model act (the "RBC Model Act") that has been adopted by the
insurance regulatory authorities. The RBC Model Act requires that life insurers
annually submit a report to state regulators regarding their RBC based upon four
categories of risk: asset risk; insurance risk; interest rate risk and business
risk. The capital requirement for each is determined by applying factors that
vary based upon the degree of risk to various asset, premiums and policy benefit
reserve items. The formula is an early warning tool to identify possible weakly
capitalized companies for purposes of initiating further regulatory action.



                                       38

--------------------------------------------------------------------------------


As of March 31, 2020, our U.S. life insurance subsidiaries maintained statutory
capital and surplus substantially in excess of the applicable regulatory
requirements and remain well positioned to support existing operations and fund
future growth.

In Canada, an insurer's minimum capital requirement is overseen by the Office of
the Superintendent of Financial Institutions ("OSFI") and determined as the sum
of the capital requirements for five categories of risk: asset default risk;
mortality/morbidity/lapse risks; changes in interest rate environment risk;
segregated funds risk; and foreign exchange risk. As of March 31, 2020,
Primerica Life Insurance Company of Canada was in compliance with Canada's
minimum capital requirements as determined by OSFI.

Redundant Reserve Financings. The Model Regulation entitled Valuation of Life
Insurance Policies, commonly known as Regulation XXX, requires insurers to carry
statutory policy benefit reserves for term life insurance policies with
long-term premium guarantees which are often significantly in excess of the
future policy benefit reserves that insurers deem necessary to satisfy claim
obligations ("redundant policy benefit reserves"). Accordingly, many insurance
companies have sought ways to reduce their capital needs by financing redundant
policy benefit reserves through bank financing, reinsurance arrangements and
other financing transactions.

We have established Peach Re, Inc. ("Peach Re") and Vidalia Re as special
purpose financial captive insurance companies and wholly owned subsidiaries of
Primerica Life. Primerica Life has ceded certain term life policies issued prior
to 2011 to Peach Re as part of a Regulation XXX redundant reserve financing
transaction (the "Peach Re Redundant Reserve Financing Transaction") and has
ceded certain term life policies issued in 2011 through 2017 to Vidalia Re as
part of a Regulation XXX redundant reserve financing transaction (the "Vidalia
Re Redundant Reserve Financing Transaction"). These redundant reserve financing
transactions allow us to more efficiently manage and deploy our capital.

The NAIC has adopted a model regulation for determining reserves using a
principle-based approach ("principle-based reserves" or "PBR"), which is
designed to reflect each insurer's own experience in calculating reserves and
move away from a standardized reserving formula. Primerica Life adopted PBR as
of January 1, 2018. The adoption of PBR facilitated extending the premium
guarantees for Primerica Life for the entire initial term period for new sales.
The PBR regulation will significantly reduce the statutory policy benefit
reserve requirements, but will apply for business issued after the effective
date. As a result, we expect that the adoption of PBR will significantly reduce
the need to engage in future redundant reserve financing transactions for
business issued after the effective date. See Note 4 (Investments), Note 10
(Debt) and Note 16 (Commitments and Contingent Liabilities) to our consolidated
financial statements within our 2019 Annual Report for more information on these
redundant reserve financing transactions.

Notes Payable. The Company has $375.0 million of publicly-traded, Senior Notes
outstanding issued at a price of 99.843% with an annual interest rate of 4.75%,
payable semi-annually in arrears on January 15 and July 15. The Senior Notes
mature July 15, 2022. We were in compliance with the covenants of the Senior
Notes as of March 31, 2020. No events of default occurred during the three
months ended March 31, 2020.

Rating Agencies. There have been no changes to Primerica, Inc.'s Senior Notes ratings or Primerica Life's financial strength ratings since December 31, 2019.

Short-Term Borrowings. We had no short-term borrowings as of or during the three months ended March 31, 2020.



Surplus Note. Vidalia Re issued the Surplus Note in exchange for the LLC Note as
a part of the Vidalia Re Redundant Reserve Financing Transaction. The Surplus
Note has a principal amount equal to the LLC Note and is scheduled to mature on
December 31, 2030. For more information on the Surplus Note, see Note 12 (Debt)
to our unaudited condensed consolidated financial statements included elsewhere
in this report.

Off-Balance Sheet Arrangements. We have no transactions, agreements or other
contractual arrangements to which an entity unconsolidated with the Company is a
party, under which the Company maintains any off-balance sheet obligations or
guarantees as of March 31, 2020.

Credit Facility Agreement. We maintain an unsecured $200.0 million revolving
credit facility ("Revolving Credit Facility") with a syndicate of commercial
banks that has a scheduled termination date of December 19, 2022. Amounts
outstanding under the Revolving Credit Facility bear interest at a periodic rate
equal to LIBOR or the base rate, plus in either case an applicable margin. The
Revolving Credit Facility contains language that allows for the Company and the
lenders to agree on a comparable or successor reference rate in the event LIBOR
is no longer available, as is expected to happen in 2022. The Revolving Credit
Facility also permits the issuance of letters of credit. The applicable margins
are based on our debt rating with such margins for LIBOR rate loans and letters
of credit ranging from 1.125% to 1.625% per annum and for base rate loans
ranging from 0.125% to 0.625% per annum. Under the Revolving Credit Facility, we
incur a commitment fee that is payable quarterly in arrears and is determined by
our debt rating. This commitment fee ranges from 0.125% to 0.225% per annum of
the aggregate $200.0 million commitment of the lenders under the Revolving
Credit Facility. As of March 31, 2020, no amounts have been drawn under the
Revolving Credit Facility and we were in compliance with its
covenants. Furthermore, no events of default have occurred under the Revolving
Credit Facility in the three months ended March 31, 2020.

Contractual Obligations Update. There have been no material changes in contractual obligations from those disclosed in the 2019 Annual Report.


                                       39

--------------------------------------------------------------------------------





           CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

Investors are cautioned that certain statements contained in this report as well
as some statements in periodic press releases and some oral statements made by
our officials during our presentations are "forward-looking" statements.
Forward-looking statements include, without limitation, any statement that may
project, indicate or imply future results, events, performance or achievements,
and may contain the words "expect", "intend", "plan", "anticipate", "estimate",
"believe", "will be", "will continue", "will likely result", and similar
expressions, or future conditional verbs such as "may", "will", "should",
"would", and "could". In addition, any statement concerning future financial
performance (including future revenues, earnings or growth rates), ongoing
business strategies or prospects, and possible actions taken by us or our
subsidiaries are also forward-looking statements. These forward-looking
statements involve external risks and uncertainties, including, but not limited
to, those described under the section entitled "Risk Factors" included herein.

Forward-looking statements are based on current expectations and projections
about future events and are inherently subject to a variety of risks and
uncertainties, many of which are beyond the control of our management team. All
forward-looking statements in this report and subsequent written and oral
forward-looking statements attributable to us, or to persons acting on our
behalf, are expressly qualified in their entirety by these risks and
uncertainties. These risks and uncertainties include, among others:

  •  major public health pandemics, epidemics or outbreaks, specifically the
     novel coronavirus COVID-19 pandemic, could materially adversely impact
     our business, financial condition and results of operations;


  •  our failure to continue to attract new recruits, retain sales
     representatives or license or maintain the licensing of sales
     representatives would materially adversely affect our business,
     financial condition and results of operations;


  •  there are a number of laws and regulations that could apply to our
     distribution model, which could require us to modify our distribution
     structure;


  •  there may be adverse tax, legal or financial consequences if the
     independent contractor status of sales representatives is overturned;





the Company's or the independent sales representatives' violation of, or non-compliance with, laws and regulations and related claims and proceedings could expose us to material liabilities;

• any failure to protect the confidentiality of client information could


     adversely affect our reputation and have a material adverse effect on our
     business, financial condition and results of operations;

• we may face significant losses if our actual experience differs from our

expectations regarding mortality or persistency;

• the occurrence of a catastrophic event could materially adversely affect

our business, financial condition and results of operations;

• our insurance business is highly regulated, and statutory and regulatory

changes may materially adversely affect our business, financial condition

and results of operations;

• a decline in the regulatory capital ratios of our insurance subsidiaries


     could result in increased scrutiny by insurance regulators and ratings
     agencies and have a material adverse effect on our business, financial
     condition and results of operations;

• a significant ratings downgrade by a ratings organization could materially


     adversely affect our business, financial condition and results of
     operations;

• the failure by any of our reinsurers or reserve financing counterparties to


     perform its obligations to us could have a material adverse effect on our
     business, financial condition and results of operations;

• our Investment and Savings Products segment is heavily dependent on mutual

fund and annuity products offered by a relatively small number of companies,

and, if these products fail to remain competitive with other investment

options or we lose our relationship with one or more of these companies, our

business, financial condition and results of operations may be materially

adversely affected;

• the Company's or the securities-licensed sales representatives' violations


     of, or non-compliance with, laws and regulations could expose us to
     material liabilities;

• if heightened standards of conduct or more stringent licensing requirements,

such as those adopted by the Securities and Exchange Commission and those


     proposed or adopted by state legislatures or regulators or Canadian
     securities regulators, are imposed on us or the sales representatives, or
     selling compensation is reduced as a result of new legislation or
     regulations, it could have a material adverse effect on our business,
     financial condition and results of operations;


  •  if our suitability policies and procedures, or our policies and
     procedures for compliance with federal or state regulations governing
     standards of care, were deemed inadequate, it could have a material
     adverse effect on our business, financial condition and results of
     operations;

• sales force support tools may fail to appropriately identify financial needs

or suitable investment products;

• non-compliance with applicable regulations could lead to revocation of our

subsidiary's status as a non-bank custodian;

• as our securities sales increase, we become more sensitive to performance of

the equity markets;

• if one of our significant information technology systems fails, if its

security is compromised, or if the Internet becomes disabled or unavailable,


     our business, financial condition and results of operations may be
     materially adversely affected;

• the current legislative and regulatory climate with regard to cybersecurity


     may adversely affect our business, financial condition, and results of
     operations;


  •  in the event of a disaster, our business continuity plan may not be

sufficient, which could have a material adverse effect on our business,

financial condition and results of operations;

• licensing requirements will impact the size of the mortgage loan sales


     force;




                                       40

--------------------------------------------------------------------------------

• our loan business is subject to various federal and state laws, changes in


     which could affect the cost or our ability to distribute our products and
     could materially adversely affect our business, financial condition and
     results of operations;

• credit deterioration in, and the effects of interest rate fluctuations on,

our invested asset portfolio and other assets that are subject to changes in


     credit quality and interest rates could materially adversely affect our
     business, financial condition and results of operations;






valuation of our investments and the determination of when the fair value of our
available-for-sale invested assets is below amortized costs are both based on
estimates that may prove to be incorrect;

• changes in accounting standards can be difficult to predict and could


     adversely impact how we record and report our financial condition and
     results of operations;

• the effects of economic down cycles could materially adversely affect our

business, financial condition and results of operations;

• we are subject to various federal, state and provincial laws and regulations

in the United States and Canada, changes in which or violations of which may

require us to alter our business practices and could materially adversely

affect our business, financial condition and results of operations;

• litigation and regulatory investigations and actions may result in financial

losses and harm our reputation;

• the current legislative and regulatory climate with regard to financial


     services may adversely affect our business, financial condition, and
     results of operations;

• the inability of our subsidiaries to pay dividends or make distributions


     or other payments to us in sufficient amounts would impede our ability to
     meet our obligations and return capital to our stockholders;

• a significant change in the competitive environment in which we operate


     could negatively affect our ability to maintain or increase our market
     share and profitability;


  •  the loss of key employees and sales force leaders could negatively
     affect our financial results and impair our ability to implement our
     business strategy;

• we may be materially adversely affected by currency fluctuations in the

United States dollar versus the Canadian dollar; and


  • the market price of our common stock may fluctuate.

Developments in any of these areas could cause actual results to differ materially from those anticipated or projected or cause a significant reduction in the market price of our common stock.



The foregoing list of risks and uncertainties may not contain all of the risks
and uncertainties that could affect us. In addition, in light of these risks and
uncertainties, the matters referred to in the forward-looking statements
contained in this report may not in fact occur. Accordingly, undue reliance
should not be placed on these statements. We undertake no obligation to publicly
update or revise any forward-looking statements as a result of new information,
future events or otherwise, except as otherwise required by law.

© Edgar Online, source Glimpses